---
title: "Gunnebo India Pvt Ltd (513175) — Share Price, Financials & Analysis"
symbol: "513175"
company: "Gunnebo India Pvt Ltd"
canonical: "https://tapetide.com/stocks/513175"
bse_code: "513175"
generated_at: "2026-10-13T10:59:29.957Z"
---

# Gunnebo India Pvt Ltd (513175)

Canonical page: https://tapetide.com/stocks/513175

## Company

- **BSE Code:** 513175
- **Stock Type:** EQUITY
- **Face Value:** ₹10
- **F&O Eligible:** No
- **Website:** steelage-india.com

## Latest Price

## Key Insights

### Strengths

- Company has reduced debt.
- Company is almost debt free.
- Company has a good return on equity (ROE) track record: 3 Years ROE 17.5%

### Weaknesses

- The company has delivered a poor sales growth of -0.08% over past five years.

## Growth Rates

| Metric | 1Y | 3Y | 5Y |
| --- | --- | --- | --- |
| net income growth | -28% | -18% | -7% |
| revenue growth | -15% | -8% | 0% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 4302 | 4418 | 4847 | 4851 | 4944 | 5086 | 5589 | 5527 | 5592 | 5842 | 6304 | 6477 |
| Expenses | 3814 | 3909 | 4219 | 4237 | 4303 | 4410 | 4774 | 4765 | 4822 | 4990 | 5362 | 5512 |
| Operating Profit | 488 | 509 | 628 | 614 | 640 | 675 | 816 | 762 | 770 | 852 | 941 | 965 |
| OPM % | 11 | 12 | 13 | 13 | 13 | 13 | 15 | 14 | 14 | 15 | 15 | 15 |
| Other Income | 20 | 34 | 26 | 29 | 37 | 49 | 44 | 69 | 72 | 54 | 61 | 48 |
| Interest | 95 | 106 | 111 | 113 | 119 | 116 | 118 | 110 | 115 | 108 | 110 | 113 |
| Depreciation | 159 | 167 | 163 | 167 | 190 | 177 | 184 | 185 | 211 | 215 | 218 | 219 |
| Profit before tax | 254 | 270 | 379 | 363 | 368 | 430 | 557 | 536 | 516 | 583 | 675 | 682 |
| Tax % | 43 | 36 | 34 | 30 | 30 | 27 | 29 | 29 | 20 | 24 | 27 | 24 |
| Net Profit | 146 | 173 | 249 | 254 | 258 | 316 | 396 | 379 | 414 | 441 | 494 | 516 |
| EPS in Rs | 10.05 | 11.59 | 16.2 | 17.06 | 17.65 | 21.23 | 26.34 | 25.89 | 27.1 | 30.1 | 33.19 | 34.93 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2008 9m | Mar 2009 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 79 | 117 | 214 | 284 | 370 | 368 | 315 | 335 | 283 |
| Expenses | 77 | 111 | 178 | 225 | 291 | 297 | 263 | 283 | 245 |
| Operating Profit | 2 | 6 | 36 | 59 | 79 | 71 | 52 | 52 | 38 |
| OPM % | 2.1 | 5 | 17 | 21 | 21 | 19 | 17 | 15 | 13 |
| Other Income | 3 | 3 | 0 | 0 | 11 | 8 | 9 | 14 | 10 |
| Interest | 3 | 2 | 0 | 0 | 1 | 1 | 1 | 1 | 0 |
| Depreciation | 2 | 2 | 0 | 0 | 4 | 5 | 5 | 6 | 4 |
| Profit before tax | 0 | 4 | 36 | 59 | 85 | 74 | 55 | 59 | 43 |
| Tax % | 432 | 16 | 30 | 34 | 31 | 31 | 34 | 35 | 35 |
| Net Profit | -1 | 4 | 25 | 39 | 58 | 50 | 36 | 39 | 28 |
| Dividend Payout % | 0 | 0 | 0 | 0 | 68 | 0 | 0 | 0 | 0 |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2008 | Mar 2009 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 3 | 3 | 0.06 | 0.06 | 0.06 | 0.06 | 0.06 | 0.06 | 0.06 |
| Reserves | -22 | -18 | 42 | 82 | 90 | 140 | 176 | 215 | 248 |
| Borrowings | 56 | 46 | 8 | 8 | 8 | 8 | 8 | 8 | 0 |
| Other Liabilities | 29 | 28 | 55 | 61 | 108 | 63 | 65 | 63 | 75 |
| Total Liabilities | 67 | 60 | 105 | 150 | 206 | 212 | 249 | 287 | 323 |
| Fixed Assets | 14 | 14 | 18 | 30 | 31 | 28 | 47 | 49 | 49 |
| CWIP | 1 | 0 | 5 | 0 | 0 | 2 | 2 | 0 | 1 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 52 | 46 | 83 | 120 | 175 | 181 | 200 | 238 | 274 |
| Total Assets | 67 | 60 | 105 | 150 | 206 | 212 | 249 | 287 | 323 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2008 | Mar 2009 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | 0 | 11 | 24 | 39 | 27 | 39 | 30 | 39 | 26 |
| Cash from Investing Activity | -2 | -1 | -6 | -9 | 0 | 0 | -11 | 8 | 3 |
| Cash from Financing Activity | 4 | -12 | -25 | 0 | -4 | -47 | 0 | 0 | 0 |
| Net Cash Flow | 1 | -2 | -7 | 29 | 24 | -8 | 19 | 47 | 29 |
| Free Cash Flow | -3 | 10 | 14 | 26 | 22 | 33 | 12 | 32 | 20 |
| CFO/OP | 49 | 201 | 97 | 100 | 71 | 56 | 57 | 76 | 68 |

### Ratios

| Item | Mar 2008 | Mar 2009 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 127 | 90 | 43 | 38 | 45 | 59 | 76 | 68 | 83 |
| Inventory Days | 142 | 55 | — | — | 57 | 45 | 48 | 55 | 72 |
| Days Payable | 188 | 119 | — | — | 94 | 82 | 102 | 98 | 143 |
| Cash Conversion Cycle | 81 | 26 | 43 | 38 | 8 | 22 | 23 | 25 | 12 |
| Working Capital Days | 75 | 40 | -16 | -10 | -31 | 22 | 31 | 31 | 34 |
| ROCE % | — | 18 | — | 84 | 91 | 61 | 34 | 29 | 18 |

## Shareholding Pattern

### annual

| Category | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Dec 2025 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 34.35% | 34.39% | 34.4% | 30.81% | 29.82% | 29.33% | 29.33% | 29.33% | 29.34% | 28.02% |
| FIIs | 46.87% | 48.54% | 44.27% | 46.92% | 54.51% | 50.81% | 46.96% | 45.63% | 42.74% | 43.54% |
| DIIs | 4.33% | 8.05% | 12.9% | 14.78% | 9.25% | 12.93% | 17.76% | 19.55% | 22.29% | 21.5% |
| Government | 0.23% | 0.23% | 0.23% | 0.23% | 0.23% | 0.23% | 0.23% | 0.23% | 0.23% | 0.23% |
| Public | 14.21% | 8.78% | 8.2% | 7.25% | 6.2% | 6.7% | 5.72% | 5.26% | 5.41% | 6.71% |
| No. of Shareholders | 7513 | 44050 | 44821 | 60310 | 67091 | 126226 | 131937 | 130664 | 134058 | 178648 |

### Quarterly

| Category | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 29.33% | 29.33% | 29.33% | 29.33% | 29.33% | 29.33% | 29.33% | 29.33% | 29.34% | 29.34% | 28.02% | 28.02% |
| FIIs | 46.96% | 47.93% | 46.15% | 46.25% | 45.63% | 43.92% | 45.37% | 45.27% | 42.74% | 43.49% | 44.2% | 43.54% |
| DIIs | 17.76% | 17.02% | 18.59% | 18.87% | 19.55% | 21.13% | 19.94% | 19.97% | 22.29% | 21.34% | 21.12% | 21.5% |
| Government | 0.23% | 0.23% | 0.23% | 0.23% | 0.23% | 0.23% | 0.23% | 0.23% | 0.23% | 0.23% | 0.23% | 0.23% |
| Public | 5.72% | 5.49% | 5.68% | 5.32% | 5.26% | 5.38% | 5.12% | 5.21% | 5.41% | 5.61% | 6.43% | 6.71% |
| No. of Shareholders | 131937 | 120030 | 131565 | 119578 | 130664 | 127754 | 119245 | 127802 | 134058 | 141007 | 160556 | 178648 |

## Filings & Documents

### Other Documents

| Date | Document |
| --- | --- |
| 2026-02-14 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/xml-data/corpfiling/AttachHis/b538c31d-97ce-4cd2-9115-ceb43a0e509b.pdf) |
| 2026-02-12 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/xml-data/corpfiling/AttachHis/7283643c-9fb9-4e48-8a01-a43a9bd6f8ce.pdf) |
| 2026-02-10 | [Announcement under Regulation 30 (LODR)-Acquisition](https://www.bseindia.com/xml-data/corpfiling/AttachHis/80e4936a-b879-46f6-a4d9-c60cebbabf35.pdf) |
| 2026-02-10 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation](https://www.bseindia.com/xml-data/corpfiling/AttachHis/04595db6-1831-4cf7-8968-32f3bfa87953.pdf) |
| 2026-02-10 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/xml-data/corpfiling/AttachHis/2256258c-6663-42bc-866c-402f5dcc1cae.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| 2025 | [Financial Year 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/330724b4-fb72-4577-beb0-598b4672f77a.pdf) |
| 2024 | [Financial Year 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/93fc23fd-104c-47e7-bfc9-cf91d3d41e33.pdf) |
| 2023 | [Financial Year 2023](https://www.bseindia.com/xml-data/corpfiling/AttachHis/30d2900c-1d8f-4110-abf9-5e477e6ace9e.pdf) |
| 2022 | [Financial Year 2022](https://www.bseindia.com/bseplus/AnnualReport/508869/74069508869.pdf) |
| 2021 | [Financial Year 2021](https://www.bseindia.com/bseplus/AnnualReport/508869/69378508869.pdf) |
| 2020 | [Financial Year 2020](https://www.bseindia.com/bseplus/AnnualReport/508869/65485508869.pdf) |
| Mar 2019 | [Financial Year 2019](https://www.bseindia.com/bseplus/AnnualReport/508869/5088690319.pdf) |
| 2018 | [Financial Year 2018](https://www.bseindia.com/HIS_ANN_RPT/HISTANNR/2018/APOLLO_HOSPITALS_ENTERPRISE_LTD-508869-MARCH-2018.PDF) |
| Mar 2017 | [Financial Year 2017](https://www.bseindia.com/bseplus/AnnualReport/508869/5088690317.pdf) |
| Mar 2016 | [Financial Year 2016](https://www.bseindia.com/bseplus/AnnualReport/508869/5088690316.pdf) |

### Earnings Call Documents

| Date | Document |
| --- | --- |
| Feb 2026 | Concall - Feb 2026 |
| Nov 2025 | Concall - Nov 2025 |
| Aug 2025 | Concall - Aug 2025 |
| Jun 2025 | Concall - Jun 2025 |
| May 2025 | [Concall - May 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/14a059cf-24b8-4d1a-a641-c917bfff7dda.pdf) |
| May 2025 | [Concall - May 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/b850535c-b6c7-417c-9899-007a8bd0d2c8.pdf) |
| Feb 2025 | Concall - Feb 2025 |
| Nov 2024 | Concall - Nov 2024 |
| Aug 2024 | Concall - Aug 2024 |
| May 2024 | Concall - May 2024 |

### Credit Rating Reports

| Date | Document |
| --- | --- |
| 2026-01-27 | Credit rating update — CRISIL |
| 2025-09-22 | Credit rating update — CRISIL |
| 2025-07-09 | Credit rating update — CRISIL |
| 2025-06-10 | Credit rating update — CRISIL |
| 2025-01-24 | Credit rating update — India Ratings |
| 2024-06-11 | Credit rating update — CRISIL |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-10-13T10:59:29.957Z.